Advisory issued for the sale of Schedule X, H & H1 drugs in Kashmir. Here are details 

SRINAGAR: Divisional Commissioner Kashmir has issued an advisory for the sale of Schedule X, H and H1 drugs in Kashmir and display of advisory issued at a conspicuous place has been made mandatory.

“Mention on the prescription the date of dispensing, number of tablets dispensed along with stamp of chemist for Schedule H, H1 and X drugs, All records and registers shall be maintained as indicated in the Act/Rules. They should be made available for inspection for the Commissioner of Food & Drugs Control Administration or any other officer authorised by him in this regard, Chemists dispensing Scheduled drugs must ensure safety control measures such as video cameras. The prescription shall be dispensed only if it is presented within 7 days of its issue, for each Schedule HI and X medicine dispensed, the pharmacist must record the: name, address, patients DoB, name of medicine supplied and quantity supplied, prescription date and dispense- Ing date, name and address of the prescriber and hen storing or archiving records and data, pharmacies should ensure they are able to locate and retrieve individual document or information when needed,” reads an advisory.

“Dispense medications if prescription is incomplete, has alteration(s) without any countersign by the doctor, dispense tramadol, buprenorphine, tapentadol, co- deine, methylphenidate for any online prescriptions, dispense psychotropic to minors not accompanied by guardians, dispense a prescription when you have reasonable cause to believe that prescription has been forged or obtained fraudulently and if forged, retain the prescription and forward it to the authorities, dispense medications if you do not have required license-for drugs like Schedule X, Breach confidentiality -misuse of personal infor- mation of the patient as well as of doctor and be a party to helping others evade laws like Drugs and Cosmetics Act, 1940; Pharmacy Act, 1948; Nar- cotic Drugs and Psychotropic substances Act, 1985; Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954,” the advisory adds further.